Fig. 1
From: A precision medicine classification for treatment of acute myeloid leukemia in older patients
Genetic group assignment algorithm. Patients were assigned to a genetic group with initial run-through of the algorithm based on cytogenetic features or molecular mutational clones with VAF ≥ 0.3. For patients not assigned to any genetic group during the initial stratification, a second run-through of the algorithm was performed with assignment after assessing for a mutational clone with VAF ≥ 0.2. CBF, Core-Binding Factor; Complex, Complex karyotype